基于多糖的新型光聚合物药物输送系统,含有用于状细胞癌治疗的天然提取物
Jianchuan Wu1, Kun Yang1, Jinfan Zhou1
1Department of Medical Cosmetology, The Second People's Hospital of Deyang, Sichuan, 618000, China.
Carbohydrate research
|May 17, 2025
概括
研究人员开发了一种用于药物输送的新型协调聚合物 (CP). 这个新的系统,PVA-PGA@CP1@1@巴西,显示了针对性状细胞癌 (SCC) 治疗的希望.
科学领域:
- 材料科学 材料科学 材料科学
- 纳米技术 纳米技术
- 生物医学工程 生物医学工程
背景情况:
- 协调聚合物 (CP) 为高级应用提供了多功能平台.
- 开发有效的药物输送系统对于向治疗至关重要.
- 像聚乙烯醇 (PVA) 和聚氨酸 (PGA) 这样的可生物降解聚合物对生物医学应用具有前景.
研究的目的:
- 合成一种新的N-捐赠者和O-捐赠者协调聚合物.
- 构建一种可生物降解的基于聚合物的药物输送系统,利用合成的CP.
- 评估药物输送系统在向状细胞癌 (SCC) 治疗中的潜力.
主要方法:
- 协调聚合物Co ((ptda) ((bib) 的溶热合成.
- 使用单晶X射线衍射和元素分析进行结构性表征.
- 使用PVA-PGA作为载体外制造一种药物输送系统 (PVA-PGA@CP1@1@巴西).
- 在体外细胞实验中评估对SCC的治疗疗效.
主要成果:
- 新型协调聚合物的成功合成和表征.
- 在CP和聚合物矩阵内封装化合物1和巴西因的功能性药物递送系统的开发.
- 证明了PVA-PGA@CP1@1@巴西系统在体外针对性SCC治疗的潜力.
结论:
- 这种新型协调聚合物作为先进药物输送系统的可行组件.
- 该PVA-PGA@CP1@1@巴西系统显示了向状细胞癌治疗的潜力.
- 这项研究提出了针对癌症向治疗的临床开发的新策略.
相关概念视频
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


